![Valentin Fulga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Valentin Fulga
Chief Executive Officer at
Theravitae Co. Ltd.
Profile
Valentin Fulga is the founder.
He founded Theravitae Co. Ltd. in 2003 and currently holds the title of Chief Executive Officer.
Dr. Fulga also held former positions at TheraVitae, Inc. as Chairman, President & Chief Executive Officer, at Hemostemix, Inc. as Director, and at W World Corp.
as Principal.
Dr. Fulga obtained an undergraduate degree from Ben-Gurion University of the Negev.
Valentin Fulga active positions
| Companies | Position | Start |
|---|---|---|
Theravitae Co. Ltd.
 Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Chief Executive Officer | 01/01/2003 |
Former positions of Valentin Fulga
| Companies | Position | End |
|---|---|---|
| W WORL | Corporate Officer/Principal | - |
| HEMOSTEMIX INC. | Director/Board Member | - |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Chief Executive Officer | - |
Training of Valentin Fulga
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
W World Corp.
 W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Health Technology |
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravitae Co. Ltd.
Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Health Technology |
Hemostemix, Inc.
 Hemostemix, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes blood-derived stem cell therapies for medical conditions | Health Technology |
- Stock Market
- Insiders
- Valentin Fulga
